国: アメリカ合衆国
言語: 英語
ソース: NLM (National Library of Medicine)
CAPSTAR Tablets contain 11.4 or 57.0 mg of nitenpyram, which belongs to the chemical class of neonicotinoids. Nitenpyram kills adult fleas., CAPSTAR Tablets contain 11.4 or 57.0 mg of nitenpyram, which belongs to the chemical class of neonicotinoids. Nitenpyram kills adult fleas.
Novartis Animal Health US, Inc.
OTC
New Animal Drug Application
CAPSTAR- NITENPYRAM TABLET NOVARTIS ANIMAL HEALTH US, INC. ---------- CAPS TAR CAPS TAR® (NITENPYRAM) CAPSTAR® is an oral tablet for dogs, puppies, cats and kittens 2 POUNDS OF BODY WEIGHT OR GREATER AND 4 WEEKS OF AGE AND OLDER. ACTIVE INGREDIENTS CAPSTAR Tablets contain 11.4 or 57.0 mg of nitenpyram, which belongs to the chemical class of neonicotinoids. Nitenpyram kills adult fleas. WARNINGS Not for human use. Keep this and all drugs out of the reach of children. DIRECTIONS CAPSTAR Tablets kill adult fleas and are indicated for the treatment of flea infestations on dogs, puppies, cats and kittens 2 POUNDS OF BODY WEIGHT OR GREATER AND 4 WEEKS OF AGE AND OLDER. A single dose of CAPSTAR should kill the adult fleas on your pet. If your pet gets re-infested with fleas, you can safely give another dose as often as once per day. To give CAPSTAR Tablets, place the pill directly in your pet’s mouth or hide it in food. If you hide the pill in food, watch closely to make sure your pet swallows the pill. If you are not sure that your pet swallowed the pill, it is safe to give a second pill. Treat all infested pets in the household. Fleas can reproduce on untreated pets and allow infestations to persist. DOS AGE CAPSTAR Tablets should be administered according to the following schedule. WEIGH YOUR PET PRIOR TO ADMINISTRATION TO ENSURE PROPER DOSAGE. DO NOT ADMINISTER TO PETS UNDER 2 POUNDS. *Please see separate insert in this package for concurrent dosing of CAPSTAR Tablets and PROGRAM® (lufenuron) Flavor Tabs®. ADVERSE REACTIONS Pre-approval laboratory and clinical studies showed that CAPSTAR Tablets are safe for use in dogs and cats, puppies and kittens 2 POUNDS OF BODY WEIGHT OR GREATER AND 4 WEEKS OF AGE AND OLDER. (SEE POST-APPROVAL EXPERIENCE SECTION). POST-APPROVAL EXPERIENCE (REV. 2011): The following adverse events are based on post-approval adverse drug experience reporting. Not all adverse reactions are reported to FDA CVM. It is not always possible to reliably estimate the adverse event frequency or esta 完全なドキュメントを読む